CGTX vs MSFT: Which Stock is Better?
Side-by-side comparison of Cognition Therapeutics Inc and Microsoft Corp in 2026
CGTX
Cognition Therapeutics Inc
$1.19
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | CGTX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $106.33M | N/A | CGTX |
| P/E Ratio | N/A | 26.46 | MSFT |
| EPS (TTM) | $N/A | $15.98 | MSFT |
| Revenue Growth | 0.0% | 0.2% | MSFT |
| Gross Margin | 0.0% | 68.6% | MSFT |
Analyze CGTX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGTX or MSFT a better investment?
Comparing CGTX and MSFT: Cognition Therapeutics Inc has a market cap of $106.33M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGTX and MSFT?
CGTX (Cognition Therapeutics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGTX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGTX or MSFT?
MSFT has higher revenue growth at 0.2% vs 0.0% for CGTX.
Which company is more profitable: CGTX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 0.0% for CGTX.
Which is the larger company: CGTX or MSFT?
Cognition Therapeutics Inc (CGTX) is larger with a market cap of $106.33M compared to N/A for MSFT.
Should I buy CGTX or MSFT in 2026?
Both CGTX and MSFT have investment merit. CGTX trades at $1.19 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGTX and MSFT stock?
Key differences: Market Cap ($106.33M vs N/A), P/E Ratio (N/A vs 26.5x), Revenue Growth (0.0% vs 0.2%), Gross Margin (0.0% vs 68.6%).